Literature DB >> 1499220

Structure, expression, and regulation of the major noncollagenous matrix proteins of bone.

M F Young1, J M Kerr, K Ibaraki, A M Heegaard, P G Robey.   

Abstract

The noncollagenous proteins (NCPs) that predominate the bone matrix have recently been the focus of intense investigation because of their potential influence on cell attachment, Ca2+ and hydroxyapatite binding, and the mineralization of bone tissue. With the advent of molecular biology, all of the major NCPs of bone have been cloned and their amino acid sequences completely determined. While each of the proteins has distinct structural properties, some proteins appear to be part of gene families. Examples include the small proteoglycans, decorin and biglycan, as well as the gamma carboxyglutamic acid proteins, such as matrix gla protein and osteocalcin (bone gla protein). Some of the NCPs that are clearly not members of any known gene family still share several common characteristics. One such example of this "convergent evolution" is bone sialoprotein and osteopontin. Both are highly posttranslationally modified glycoproteins that share the cell attachment amino acid sequence RGD (arginine-glycine-aspartic acid), which facilitates the attachment of bone cells in vitro, yet they are clearly not related genetically. Using cDNAs and antisera as probes, the precise temporal localization of NCP expression has been determined, and it has been shown that NCPs are produced in skeletal, and in most cases, nonskeletal tissue as well. This observation implies that the functions of the NCPs are not necessarily limited to bone tissue. Many of the promoters for these genes have been isolated and functional domains determined by a combination of chloramphenicol acetyltransferase assay, gel shift, and footprint analyses. The most extensively studied promoter in the NCP category is osteocalcin, whose sensitivity to 1,25-dihydroxycholecalciferol has been delineated in detail. Future studies on the individual and cooperative activities of the NCPs in bone are likely to involve site-directed mutagenesis of cloned DNA and a combination of in vitro and in vivo functional analyses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499220

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  33 in total

1.  A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone.

Authors:  Richard Tuli; M Reza Seghatoleslami; Suraj Tuli; Mark L Wang; William J Hozack; Paul A Manner; Keith G Danielson; Rocky S Tuan
Journal:  Mol Biotechnol       Date:  2003-01       Impact factor: 2.695

2.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering.

Authors:  Fei Liu; Xu Zhang; Xixun Yu; Yuanting Xu; Ting Feng; Dawei Ren
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

Review 4.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

5.  Cell derived hierarchical assembly of a novel phosphophoryn-based biomaterial.

Authors:  Jinhua Li; Dana Olton; Donghyun Lee; Prashant N Kumta; Charles Sfeir
Journal:  Cells Tissues Organs       Date:  2008-09-25       Impact factor: 2.481

6.  The anatomy of bone sialoprotein immunoreactive sites in bone as revealed by combined ultrastructural histochemistry and immunohistochemistry.

Authors:  M Riminucci; G Silvestrini; E Bonucci; L W Fisher; P Gehron Robey; P Bianco
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

7.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

Review 8.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

9.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 10.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.